| 2021-02-11 | BROADWOOD PARTNERS, L.P. | - | Sell | 7,789 | $124.90 | $972,846.10 | - | → |
| 2021-02-09 | BROADWOOD PARTNERS, L.P. | - | Sell | 257,619 | $121.59 | $31,324,184.93 | -0.4% | → |
| 2021-02-04 | BROADWOOD PARTNERS, L.P. | - | Sell | 60,861 | $111.00 | $6,755,865.93 | -0.1% | → |
| 2021-01-28 | BROADWOOD PARTNERS, L.P. | - | Sell | 789,883 | $103.91 | $82,075,795.65 | -1.3% | → |
| 2021-01-12 | BROADWOOD PARTNERS, L.P. | - | Sell | 60,000 | $89.28 | $5,356,800.00 | -0.3% | → |
| 2020-11-23 | Francese James E | Sr. VP, Comm. Ops., NA, APAC | Sale+OE | 18,959 | $80.13 | $1,519,184.67 | -27.0% | → |
| 2020-11-23 | Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, China | Sale+OE | 21,469 | $82.39 | $1,768,834.33 | -4.6% | → |
| 2020-11-09 | Hayashida Jon K. | VP, Global Clinical, Medical | Sale+OE | 20,000 | $81.34 | $1,626,800.00 | -64.9% | → |
| 2020-11-09 | Holliday Keith | Chief Technology Officer | Sale+OE | 23,714 | $81.56 | $1,934,113.84 | -40.9% | → |
| 2020-09-15 | Holliday Keith | Chief Technology Officer | Sale+OE | 72,015 | $53.32 | $3,840,158.17 | -51.8% | → |
| 2020-09-09 | Moore John C | Director | Sell | 137,331 | $52.04 | $7,146,705.24 | -86.5% | → |
| 2020-08-10 | Hayashida Jon K. | VP, Global Clinical, Medical | Sale+OE | 41,602 | $51.22 | $2,130,854.44 | -79.4% | → |
| 2020-06-15 | Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, China | Sale+OE | 39,215 | $44.07 | $1,728,205.05 | -23.5% | → |
| 2020-06-10 | Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, China | Sale+OE | 785 | $44.00 | $34,540.00 | -0.6% | → |
| 2020-05-21 | Gesten Samuel J | Chief Legal Officer | Sale+OE | 192,522 | $40.00 | $7,700,880.00 | -82.4% | → |
| 2020-05-15 | Holliday Keith | Chief Technology Officer | Sale+OE | 25,000 | $37.69 | $942,250.00 | -46.8% | → |
| 2020-05-11 | Hansen Graydon C. | Sr. VP, Global Operations | Sale+OE | 18,189 | $39.02 | $709,707.79 | -18.8% | → |
| 2020-05-11 | Francese James E | Sr. VP, Comm. Ops., NA, APAC | Sale+OE | 18,856 | $39.06 | $736,515.36 | -29.8% | → |
| 2020-05-11 | Hayashida Jon K. | VP, Global Clinical, Medical | Sale+OE | 46,563 | $39.11 | $1,821,078.93 | -81.2% | → |
| 2020-03-23 | ANDREWS DEBORAH J | Chief Financial Officer | Sell | 834 | $27.42 | $22,868.28 | -2.6% | → |
| 2020-03-23 | Francese James E | Sr. VP, Comm. Ops., NA, APAC | Sell | 2,250 | $26.77 | $60,232.50 | -4.8% | → |
| 2020-03-23 | Hayashida Jon K. | VP, Global Clinical, Medical | Sell | 2,813 | $26.83 | $75,472.79 | -20.7% | → |
| 2020-03-23 | Hansen Graydon C. | Sr. VP, Global Operations | Sell | 2,813 | $27.42 | $77,132.46 | -12.6% | → |
| 2020-03-23 | Gesten Samuel J | Chief Legal Officer | Sell | 2,742 | $27.42 | $75,185.64 | -6.2% | → |